Executive Summary: Key Legal and Evidentiary Issues

Anaergia's Capital Sales division revenues were undisclosed as partially derived from intersegment sales to its Build Own Operate division, inflating apparent external revenue. Financial statements were materially misstated through improper revenue recognition requiring restatement of 2020-2022 figures by $13-26 million annually. The company's financial outlook assumptions—including 35-45% growth rates, Rialto full capacity by 2022, and carbon intensity score of -150—were challenged as unreasonable despite initial audit approval. Officer certifications by CEO Andrew Benedek and CFO Hani El-Kaissi falsely attested to accuracy of subsequently restated financial statements and disclosure controls. Ontario Securities Act section 138(b)'s 180-day limitation period was interpreted to exclude the common law discoverability principle, requiring actual rather than constructive knowledge. Class certification with multiple subclasses proceeded despite defendants' challenge to scope and member eligibility criteria.

Anaergia Securities Misrepresentation Class Action

Company Background and Operations

Anaergia Inc., a renewable natural gas company, completed its IPO on June 7, 2021, raising $200 million on the TSX. The company operates three divisions: Capital Sales (equipment and services), Services (operations and management), and Build Own Operate (BOO) (facility development and operation). The Rialto Bioenergy Facility in California converts organic waste into renewable natural gas, generating revenue from municipal waste tipping fees, RNG sales, and fertilizer sales. U.S. government incentives—including the EPA's Renewable Fuel Standard and California's Low Carbon Fuel Standard—enhanced RNG pricing to approximately US$67 per million British thermal units with credits versus US$2 without credits. A negative carbon intensity score yields more valuable LCFS credits, with Rialto expected to achieve a score near -150 for premium pricing.

Disclosure of Financial Outlook and Key Assumptions

The IPO prospectus projected 2022 revenues of $360-$410 million and 2023 revenues of $490-$560 million, with corresponding AEBITDA targets of $50-$60 million and $85-$105 million respectively. Three critical assumptions underlay this guidance: (1) Capital Sales and Services divisions would grow 35-45% annually, consistent with historical 41% compound annual growth from 2018-2020; (2) Rialto would operate at full capacity in 2022, generating $29 million proportionate run-rate AEBITDA; and (3) Rialto's RNG would achieve a carbon intensity score near -150, commanding premium pricing. The prospectus included cautionary language stating targets were not forecasts and offered no assurance of achievement due to potential Rialto delays. Subsequent updates in August 2021 and November 2021 disclosed COVID-related feedstock delays, extending expected full operation from "sometime in Fiscal 2022" to "sometime toward the end of 2022." The March 28, 2022 update maintained revenue and AEBITDA targets despite downward revisions to Rialto's contribution, with the company asserting assumptions remained reasonable.

Intersegment Sales and Revenue Recognition Issues

The IPO prospectus characterized Capital Sales as serving "third party customers" including municipalities and private entities. However, substantial revenues derived from intersegment transactions with Anaergia Technologies, a subsidiary providing construction services to Rialto under a contract with W.M. Lyles Co. Anaergia recognized Technologies' fees as Capital Sales revenue without eliminating the intersegment transaction in consolidated statements. KPMG, Anaergia's auditor, initially approved management's position. However, the Canadian Public Accountability Board, during routine audit quality inspection, determined that KPMG should have treated these revenues differently in segment reporting. This treatment artificially inflated Capital Sales performance, making the division appear to generate more external revenue than actually occurred. In August 2022, Anaergia announced it was revisiting this accounting interpretation.

Financial Statement Restatements and Corrected Figures

On August 15, 2022, after markets closed, Anaergia released restated 2020-2022 financial statements. Fiscal 2020 revenues decreased from $128.042 million to $110.532 million; fiscal 2021 revenues decreased from $153.581 million to $127.048 million; and first quarter 2022 revenues decreased from $39.970 million to $35.616 million. Adjusted EBITDA figures were similarly corrected, with fiscal 2021 changing from positive $5.035 million to negative $2.970 million. The company initially described these adjustments as a "technical accounting matter only," claiming it would still meet prior guidance. On November 10, 2022, Anaergia revised 2022 guidance downward to $160-$170 million revenues and withdrew 2023 guidance entirely, attributing changes to feedstock supply delays, macroeconomic factors, and construction delays. The cumulative effect overstated revenues, profits, ROE, and AEBITDA while understating losses and debt-to-equity ratios across multiple periods.

Plaintiff's Claims and Legal Issues

Mohammad Reza Kamrani-Ghadjar, who purchased 3,000 secondary market shares in March 2022, commenced a class action in March 2023 alleging material misrepresentations by Anaergia, CEO Andrew Benedek, and CFO Hani El-Kaissi. He claimed four categories of misrepresentation: (1) failure to disclose intersegment sales within Capital Sales division; (2) misstated financial performance in quarterly and annual statements; (3) unreasonable financial outlook assumptions; and (4) false officer certifications regarding disclosure accuracy. Justice Agarwal's analysis found that Kamrani-Ghadjar had a reasonable possibility of succeeding on intersegment sales omissions and financial misstatement claims. The defendants conceded that financial statements contained untrue statements of fact and that representations regarding IFRS compliance were incorrect following August 2022 restatements. Regarding financial outlook assumptions, the court determined they were reasonable when made—the 35-45% growth rate was based on bottom-up forecasting, Rialto's capacity operation was reasonably expected given feedstock and certification timelines, and the conservative -50 carbon intensity assumption was appropriate compared to comparable facilities. Expert evidence established that stock price experienced abnormal returns of -21.5% following March 28, 2022 guidance revision (expected return 0.5%) and -40% following November 10, 2022 guidance withdrawal (expected return 9.2%), both statistically significant, demonstrating market recognition of materiality.

Class Certification and Limitations Period

Justice Agarwal certified the action as a class proceeding with three subclasses: IPO investors, secondary distribution investors, and secondary market investors acquiring securities during June 7, 2021 to November 10, 2022 who held shares on specified correction dates. The court rejected defendants' arguments restricting the class to Canadian underwriter purchases and specific holding periods. Critically, the court held that Ontario Securities Act section 138(b)(i)'s 180-day limitation period operates on actual knowledge of misrepresentation facts rather than knowledge that should have been acquired through reasonable diligence. The court found the statute's reference to "knowledge of the facts" without including "ought to have known" language—despite its inclusion in other Securities Act sections—reflected deliberate legislative exclusion of the common law discoverability principle. Requiring investors to conduct expert-driven materiality analyses within 180 days would be inconsistent with the inherent complexity of securities misrepresentation claims. The three-year absolute limitation period provides issuers certainty while allowing investors reasonable time to assemble complex evidence.

Outcome and Relief

Justice Agarwal granted Kamrani-Ghadjar leave to proceed with secondary market disclosure claims for financial misstatements, intersegment sales omissions, and certification misstatements, finding a reasonable possibility of success. Leave was denied for financial outlook misstatement claims on the basis that assumptions were reasonable at inception. The action was certified as a class proceeding with the three proposed subclasses without defendants' requested limitations. The defendants' summary judgment motion on primary market claims was dismissed, with the court finding no genuine issue requiring trial regarding Kamrani-Ghadjar's knowledge of facts before September 28, 2022 (180 days prior to claim commencement). Kamrani-Ghadjar emerged as the successful party on these procedural motions. No monetary damages, awards, or costs were determined in this decision, as it addresses only threshold certification and limitations issues. The actual quantum of damages, if liability is established at trial, will be determined through common issues adjudication or settlement negotiation. The court scheduled cost submissions for December 4, 2025.